IR Banner

Posters & Publications

Date Title View
Jun 17, 2023
ENDO 2023 Oral Presentation - Growth Response of Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD): Combined Analysis Interim Analysis Data
Jun 17, 2023
ENDO 2023 Oral Presentation - LUM-201 Dose Response Measured by Acute GH, IGF-1, and Annualized Height Velocity (AHV) from Interim Analysis of OraGrowtH212 Trial in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD)
May 07, 2023
PES 2023 Oral Presentation - Growth Response to LUM-201 in the OraGrowtH210 Trial in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD): Interim Analysis Data (41 Subjects)
May 07, 2023
PES 2023 Poster - Observed IGF-1 Serum Concentration Increase Within Normal Range After Prolonged Daily Oral LUM-201 Administration in Idiopathic Pediatric Growth Hormone Deficiency from the OraGrowtH212 Trial: Interim Analysis Data
Mar 05, 2023
IMPE 2023 Oral Presentation – Dose-dependent Increase in GH AUC0-12h with LUM-201 in Idiopathic Pediatric GH Deficiency (iPGHD) from the Interim Analysis Data of the OraGrowtH212 Trial
Mar 05, 2023
IMPE 2023 Poster – Baseline Demographics of the OraGrowtH210 Trial Studying LUM-201 in Idiopathic Pediatric Growth Hormone Deficiency (iPGHD) Interim Analysis Data
Mar 30, 2022
A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial
Mar 20, 2021
LUM-201 Elicits Greater GH Response than Standard GH Secretagogues in Pediatric Growth Hormone Deficiency
Mar 04, 2021
Development of a Predictive Enrichment Marker for Oral GH Secretagogue LUM-201 in Children with Growth Hormone Deficiency
Mar 04, 2021
Corroboration of Height Velocity Prediction Markers for rhGH with an Oral GH Secretagogue Treatment in Children with GHD
Email Alerts Subscription
Download Library
Print
Share
Search Investors